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A transcriptional regulator, NmlRsp, has been identified in Streptococcus pneumoniae that is required for defense
against nitric oxide (NO) stress. The nmlRsp gene is cotranscribed with adhC,which encodes an alcohol dehydro-
genase that is able to reduce S-nitrosoglutathione (GSNO) with NADH as reductant. nmlRsp and adhC mutants
exhibited a reduced level of NADH-GSNO oxidoreductase activity and were more susceptible to killing by NO
than were wild-type cells. Comparison of the virulence of wild-type and mutant strains by use of a mouse model
system showed thatNmlRsp andAdhCdo not play a key role in the adherence of pneumococci to the nasopharynx
in vivo. An intraperitoneal challenge experiment revealed that both NmlRsp and AdhCwere required for survival
in blood. These data identify novel components of a NO defense system in pneumococci that are required for
systemic infection.
Although Streptococcus pneumoniae is a commensal bac-
terium of the nasopharynx, it is also an important cause
of human disease. A key event in pneumococcal patho-
genesis is migration from the nasopharynx to the lungs,
where the bacterium causes pneumonia. Subsequently,
the organism enters the blood, causing bacteremia. NO
is recognized as an important mediator of the innate
immune response to infection with many microorgan-
isms [1]. Recently, it has been shown that, after phago-
cytosis of pneumococci, NO contributes to the decline
in the viability of internalized bacteria [2] and that NO
has direct antibacterial activity [3].
To date, no mechanism has been proposed to explain
how the pneumococcus is able to withstand challenge
with NO. This contrasts with other pathogens, such as
Salmonella enterica ser. Typhimurium, for which de-
fense mechanisms against NO have been described [4].
Enzymes involved in this defense include hemoproteins
and respiratory enzymes with NO reductase activity;
these are absent from S. pneumoniae, which does not
possess a respiratory chain, as are key regulators of the
response to NO in enteric bacteria, NorR [5] and
NsrR [4].
We recently characterized a novel regulator of gene
expression inNeisseria gonorrhoeae,NmlR (theNeisseria
merR-like regulator), which was proposed to control a
defense system to copewith disulfide stress caused by the
action of electrophiles, including NO. This regulator
controlled the expression of a class 3 alcohol dehydroge-
nase, AdhC, which is known to catalyse the reduction of
S-nitrosoglutathione (GSNO) in microorganisms and
humans [6]. Here, we report the first description of an
NOdefense systembased on anNmlR-like regulator and
AdhC in S. pneumoniae and assess its importance in sys-
temic disease.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The S. pneu-
moniae virulent type 2 strainD39 [7] was grown overnight
on blood agar and inoculated into either serum broth
(meat-extract broth supplementedwith 10%horse serum)
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or Todd-Hewitt broth with 0.5% yeast extract (THY broth) for
growth before inoculation or challenge. D39 was transformed as
described elsewhere [8, 9], and transformants were selected on
blood agar containing 0.2g/mL erythromycin.
DNA manipulations. Chromosomal DNA was extracted
and purified using the Wizard Genomic DNA Purification Kit
(Promega) in accordance with to the manufacturer’s instruc-
tions, except that cell lysis was induced with 0.1% (wt/vol) de-
oxycholate and by incubation at 37°C for 10 min. Polymerase
chain reaction (PCR) amplification was performed in a Hybaid
Touchdown thermal cycler, and the 50-L reaction volume con-
tainedPCRbuffer (1.5mmol/LMgCl2, 10mmol/LTris [pH8.4],
50mmol/LKCl, and 100g/mL gelatine), 1.5UofTaq polymer-
ase, 1 mol/L each primer, 100 ng of DNA template, and 200
mol/L each of the 4 dNTPs. Amplification involved 25 cycles of
denaturation at 95°C for 30 s, annealing at 50°C for 30 s, and
elongation at 72°C for 1–4 min.
Construction of nmlRsp and adhC mutants. Deletion-
replacement mutations in nmlRsp and adhC were constructed
using overlap-extension PCR mutagenesis and direct trans-
formation, essentially as described elsewhere [10]. The oligo-
nucleotides used for first round PCR amplification of nmlRsp
and adhC were designed with reference to the sequences
in the genome of S. pneumoniae R6 (a derivative of D39)
(accession number NC_003098). The primers used were
as follows: upstream NmlRsp, 5'-TCAGCTAGCACGGAATA-







TATGATTGTAATCGAATAAAAAACG-3'. The primers used
for the amplification of the erythromycin-resistance cartridge
(erm from pVA891 [11]) were JM214, 5'-GAGGAGTGA-
TTACATGAAACAA-3', and JM215, 5'-CTCATAGAATTA-
TTTCCTCCC-3'. The individual PCR products were then am-
plified together to obtain a single overlap-extension PCR prod-
uct that was transformed into D39.
Phylogenetic analysis. Protein sequences of MerR family
proteins were aligned using the CLUSTALWalgorithm [12]. An
unrooted tree was constructed using PHYLIP [13].
Extraction of RNA and reverse-transcriptase PCR (RT-
PCR). RNA was isolated from bacterial pellets with acid-phe-
nol:chloroform:isoamyl alcohol (125:24:1; pH 4.5), as described
elsewhere [14]. The extract was precipitated at80°C overnight
and subsequently treated with 10 U of RNase-free DNase
(Roche) at 37°C for 60 min, to remove DNA contamination.
Relative levels of mRNA were determined using real-time RT-
PCR. The levels of 16S rRNA were used as an internal control to
standardize the amount of mRNA. Oligonucleotides for 16S
rRNA were 16sFor, 5'-GGTGAGTAACGCGTAGGTAA-3',
and 16sRev, 5'-ACGATCCGAAAACCTTCTTC-3'; oligonucle-
otides for the adhC transcript were AdhCFor, 5'-CGGATGA-
TGTGATTATTCGTGT-3', and AdhCRev, 5'-CGGCTAGACA-
TCTGCAAGAGTC-3'. Real-time RT-PCR was performed on a
RotorgeneRG-2000 thermocycler using the Superscript IIIOne-
Step RT-PCR System (Invitrogen). Quantitative fold differences
for each transcript were determined using the 2-CT method
described by Livak and Schmittgen [15].
For induction of adhCwith GSNO, pneumococci were grown
to an absorbance at 600 nm (A600) of 0.25 in THY broth and then
stressed by addition of GSNO to a final concentration of 100
mol/L. Cells were allowed to grow for an additional 20 min
before harvesting and extraction of total cellular RNA.
GSNO killing assays. Triplicate samples of D39 and the
adhC and nmlRsp mutants were grown to an A600 of 0.3–0.6 in
THY broth. Cells were resuspended in 200 L of PBS. Ten mi-
croliters of cell suspension was added to 490 L of NaOH/SDS
solution, A260 was measured, and colony-forming units per mil-
liliter was calculated using a standard curve. The volumes of the
cell suspensions were then adjusted to ensure that wild-type and
mutants had equivalent densities of colony-forming units per
milliliter. Tenmicroliters of each cell suspensionwas then added
to 90 L of PBS with or without 2.5 mmol/L GSNO in a micro-
titer plate. Ten-microliter samples were withdrawn at 10-min
intervals, serially diluted, and plated.
Measurement of NADH-GSNO oxidoreductase activity.
Cells were grown in THY broth to an A600 of 0.5–0.7. Cells were
harvested, washed twice, resuspended in 5 mL of 150 mmol/L
potassium phosphate (pH 7.0) and lysed by addition of 0.1%
deoxycholate. After 30 min at 37°C, cell debris was removed by
centrifugation at 13,000 g for 15 min, and the cell-free extract
was passed through a 0.45-m filter. GSNO-dependent oxida-
tion of NADH by cell-free extracts was followed spectrophoto-
metrically as described elsewhere [16]. Protein concentration
was measured using the Sigma Protein Determination Kit.
Intranasal colonization model. The method used was a
modification of that described elsewhere [17, 18]. Bacterial
strains used for the intranasal challenge were grown in THY
broth to an A600 of 0.25. Ten 5-week-old female CD1 mice were
anaesthetised before challenge by intraperitoneal injection with
pentobarbitone sodium (Nembutal; Rhone-Merieux); 25 L of
a mixture of S. pneumoniaeD39 and the nmlRsp mutant, at con-
centrations of1  108 cfu/mL,was pipetted into the nares and
involuntarily inhaled. Five mice were killed at 24 and 48 h after
challenge. The nasopharynx was washed with 1 mL of buffer
(0.5% trypsin and 0.02% EDTA in sterile PBS). Blood (75 L)
was collected from the heart. The mouse was perfused with ster-
ile saline, and both lungs were removed and placed in 2 mL
sterile PBS. The nasopharyngeal cavity was excised and placed in
5 mL of sterile PBS. The lungs and nasopharyngeal tissues were
then homogenized using a CAT X120 homogeniser. Samples
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were then serially diluted and plated on blood agar (supple-
mented with 0.2 g/mL erythromycin in the case of the nmlRsp
and adhCmutants) to determine the number of viable pneumo-
cocci. Differences in the level of colonization were analyzed us-
ing Student’s paired t test (2-tailed).
Intraperitoneal competition and virulence models. Five
mice were injected intraperitoneally with 0.1 mL of serum broth
containing 1  103 cfu of S. pneumoniae comprising a 1:1 mix-
ture of either D39:nmlRsp or nmlRsp:adhC. Blood was collected
from mice at 24 and 48 h, and serially diluted blood was plated
on blood agar with or without erythromycin to enumerate wild-
type and mutant S. pneumoniae. Differences in the level of colo-
nization were analyzed using Student’s paired t test (2-tailed).
Alternatively, groups of 15 mice were challenged with 1  102
cfu of each strain and were observed for 10 days. Differences in
the overall survival rates between groups were analyzed by Fish-
er’s exact test.
Adherence assay. Adherence of pneumococci to A549 cells
(human type 2 pneumocytes) andHEp-2 cells (human laryngeal
carcinoma) was determined essentially as described elsewhere
[19]. Pneumococci were suspended at a density of 1  106 cfu/
mL. Washed A549 or HEp-2 monolayers in 24-well tissue-
culture plates were infected with 1 mL of the bacterial suspen-
sion. After incubation at 37°C for 2 h, culture medium was
removed, and the monolayers were washed 4 times with PBS.
The cell monolayers were detached from the plate by treatment
with 0.25% trypsin and 0.02% EDTA. Cells were lysed by the
addition of 400 L of 0.025% Triton X-100, and serial 10-fold
dilutions thereof were plated on blood agar to determine the
number of colony-forming units of adherent bacteria.
RESULTS
Identification of a MerR-like regulator in S. pneumoniae
related to neisserial NmlR. The MerR family of regulators
sense a variety of physiological changes (reviewed in [20]). Three
merR-like genes were identified in the genome of S. pneumoniae
D39, and the protein encoded by one of these, Spr1671, aligned
most closely with N. gonorrhoeae NmlR. We have named
Spr1671 “the NmlR-like regulator of pneumococcus,” or
nmlRsp. In an earlier study, we observed that 2 cysteine residues
(at positions 54 and 71 in NmlR) were conserved within the
proteins of theNmlR subfamily, although it should be noted that
NmlR itself possesses 4 cysteine residues [16]. NmlR-like regu-
lators have been identified in several streptococcal species (figure
1), and these form a distinct clade within theMerR family. These
streptococcal transcription factors possess only a single cysteine
(C54), except for the NmlR from Streptococcus agalactiae, in
which a tyrosine residue replaced the cysteine (data not shown).
Available sequenced S. pneumoniae genomes and our in-house
Figure 1. Unrooted phylogenetic tree of NmlRsp and selected MerR regulators. Sequences are indicated by name and accession no., as follows: ZntR
(P36676), MerR (P06688), CueR (P77565), ZccR (CAE43000), SctR (AF409088), BmrR (P39075), BltR (L32599), PbrR (CAC28872.1), CadR (AAK48830), and
HmrR (NP_435795). The NmlR clade is EF2330 (ZP_00037431), Enterococcus faecium; OB785 (BAC12741), Oceanobacillus iheyensis; CAP0107
(AKK76852), Clostridium acetobutylicum; Lmo1478 (CAC99556.1), Listeria monocytogenes EGD-e; Lp3013 (NP_786333.1), Lactobacillus plantarum;
HI0186 (I64052), Haemophilus influenzae; and NMA1517 (CAB84745), Neisseria meningitidis. The Streptococcus subgroup is Spr1671 (NP_359263), S.
pneumoniae R6; SAG0427 (NP_687461), S. agalactiae 2603 V/R; SMU0677 (NP_721105), S. mutans UA159; and SMT0978, S. mitis NCTC 12261.
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microarray data show that nmlRsp is present in all strains exam-
ined (including serotypes 1, 2, 3, 4, 6, 11, 14, and 23F).
Transcriptional coupling of a gene encoding a class III
alcohol dehydrogenase to nmlRsp. The nmlRsp gene is flanked
by genes predicted to encode a zinc-containing alcohol dehydro-
genase (adhC; Spr1670) and a cation efflux system protein of the
CDF family (czcD; Spr1672) (figure 2). All 3 genes are predicted
to be transcribed from the sameDNA strand. The spacing of 243
bp between the end of czcD and nmlRsp is sufficient for a MerR-
regulated promoter. It also appears that adhC is transcriptionally
coupled to nmlRsp, given that there is no gap between the stop
codon for nmlRsp and the start codon for adhC (figure 2). This
was confirmed using RT-PCR (data not shown). The N. gonor-
rhoeae adhC is also adjacent to nmlR [16], but the genetic ar-
rangement is different because the 2 genes are transcribed from
opposite strands. MerR regulators are targeted to promoters
with a characteristic elongated 35 to 10 spacer region, usu-
ally between 2 overlapping promoters of divergently transcribed
genes, each with a sequence exhibiting dyad symmetry [20]. The
nmlRsp promoter exhibits the characteristic 19-bp spacer con-
taining a dyad symmetry between the 10 and 35 elements
(figure 2).
Requirement of NmlRsp and AdhC for resistance to nitro-
sative stress. To assess the physiological role played by nmlRsp
and adhC, we constructed a deletion-replacement mutation in
the highly virulent type 2 S. pneumoniae strainD39. That portion
of thenmlRsp open reading frame encoding aa 1–115 (of a total of
117 aa) was replaced in-frame with an erythromycin-resistance
cartridge (erm from pVA891) by overlap-extension PCR and
transformation of D39. The last 3 codons of nmlRsp (encoding aa
116–117 plus the stop codon) were left intact so as not to disturb
the putative ribosome-binding site for the downstream gene. A
similar approach was used to construct an adhCmutant.
Because it has been established that different AdhC enzymes
are able to reduce GSNO, we tested the effect of mutations in
nmlRsp and adhC on the ability of pneumococci to survive nitro-
sative stress. Figure 3A shows the effect of challenge with GSNO
(2.5 mmol/L for 60 min) on the survival of S. pneumoniae D39
and its otherwise isogenic nmlRsp and adhCmutants. Both mu-
tants exhibited hypersusceptibility to NO stress, with viability
after a 60-min exposure significantly reduced to 4.17% and
0.39% of that of the wild-type strain for the nmlRsp mutant and
the adhC mutant, respectively (P  .0002 and P  .0003, re-
spectively).
NADH-dependent GSNO reductase activity was assayed in
lysates of D39 as well as the adhC and nmlRsp mutants, as de-
scribed inMaterials andMethods (figure 3B). The results closely
paralleled theGSNOsurvival data, withGSNOreductase activity
Figure 2. Organization of the intergenic region between the czcD gene and the upstream promoter region of NmlRsp (Spr1671). The translational start
of nmlRsp is indicated by boldface type, and the proposed 10 and 35 promoter elements are marked and indicated by italics; below is the
consensus sequence of these elements. The small arrows show the region of dyad symmetry that lies between the promoter elements. The putative
ribosome-binding site (RBS) is underscored. The arrowheads on the open reading frames indicate the direction of transcription.
Figure 3. Phenotype of adhC and nmlRsp mutants. A, Percentage of
survival (relative to that of wild-type [WT] D39 cfu/mL survival) after a
60-min exposure to 2.5 mmol/L S-nitrosoglutathione (GSNO). B, NADH-
GSNO oxidoreductase activity in mutant and WT strains (mol of NADH
consumed/min/mg of protein).
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in the nmlRsp and adhC cell-free extracts reduced to 50% (0.15 U)
and 28% (0.08 U) of that for the wild type (0.30 U), respectively.
Induction of adhC expression by NO stress. We examined
the level of adhCmRNAby real-timeRT-PCR. The adhCmRNA
level was 6.25-fold lower in the nmlRsp mutant compared with
D39, suggesting that transcription of the nmlRsp-adhC operon is
under the direct control of NmlRsp. However, transcription of
adhC was not completely abolished, presumably because of re-
sidual promoter activity, since the10 and35 regions and the
ribosomebinding site are left intact in thenmlRspmutant. To test
whether NO stress could induce transcription of adhC in S.
pneumoniae,we compared the level of adhCmRNA in wild-type
D39 and nmlRsp mutant cells stressed for 20 min by the addition
of GSNO at a final concentration of 100 mol/L. The level of
transcription for adhC in theD39 parent was 4-fold higher in the
GSNO-treated bacteria than in the nonstressed control culture.
In comparison, there was no induction of adhC mRNA by
GSNO in the nmlRsp mutant. This clearly indicates that GSNO
can induce adhC transcription and that induction requires the
regulator NmlRsp.
Contribution of NmlRsp and AdhC to systemic virulence of
S. pneumoniae but not to nasopharyngeal colonization or
adherence to respiratory epithelial cells. The hypersensitivity
to NO caused by the mutation of either nmlRsp or adhC could
potentially affect the virulence of S. pneumoniae D39. To exam-
ine this possibility, we measured the capacity of the mutants to
compete with either D39 or each other in an intraperitoneal
challenge model. In the first experiment, 5 mice were injected
with1  103 cfu of a 1:1 mix of D39 and the nmlRsp mutant.
Blood was collected at 24 and 48 h, and the numbers of each
strain were determined after plating on blood agar with or with-
out erythromycin. As shown in figure 4A, in each mouse, the
number of wild-type D39 bacteria was several orders of magni-
tude greater than that of the nmlRsp mutant. The mean compet-
itive index of themutant with respect to the wild-type strain was
0.008 and 0.0036 at 24 and 48 h, respectively. These differences
in the capacity to survive in the blood were highly significant
(P  .004 and P  .034, respectively). In the second experi-
ment (figure 4B), competitive intraperitoneal challenge of mice
with 1  103 cfu of the nmlRsp and adhC mutants at a 1:1 ratio
showed that the latter is less fit than the former (figure 4B). The
mean competitive index of the adh mutant with respect to the
nmlRsp mutant was 0.11 and 0.10 at 24 and 48 h, respectively.
These differences were also significant (P  .002 and P  .011,
respectively).
In view of the significant systemic attenuation of both the
nmlRsp and adhCmutants with respect to D39, the fitness of the
nmlRsp mutant and the wild-type strain were also compared in
an intranasal challenge model of nasopharyngeal colonization
and lung infection. After intranasal challenge, there was no sig-
nificant difference in the capacity of the 2 strains to survive in the
nasopharyngeal niche (competitive index of1.0). In the lungs,
the nmlRsp mutant showed a small decrease in fitness relative to
D39 at 24 and 48 h (competitive indices of 0.5 and 0.1, respec-
tively), but this trend did not reach statistical significance. We
also directly compared the intraperitoneal virulence of D39 and
the nmlRsp and adhC mutants. Mice were challenged with
1  102 cfu of either D39, the nmlRsp mutant, or the adhCmu-
tant, and their survival was followed over 10 days. The survival
rate for mice challenged with D39 was 4/15 (median survival
time, 4.08 days), compared with 13/15 and 11/15 for the groups
challenged with the nmlRsp and adhC mutants (P  .0025 and
P  .027, respectively).
We also compared the ability of the nmlRspmutant andD39 to
adhere toDetroit 562 (humannasopharyngeal) or A549 (human
type II pneumocytes) cells in vitro but were unable to show any
significant difference in adherence to either cell line (data not
shown). Collectively, these findings suggest that NmlRsp does
Figure 4. Systemic virulence competition assay. Equal nos. of D39
(black squares) and the nmlRsp mutant (white squares) were injected
intraperitoneally, and the nos. of each strain were determined in blood
collected at 24 and 48 h, as described in Materials and Methods (A). Data
are shown for each of 5 mice (m1–m5). Panel B shows results for a
similar competition experiment after coinjection of the nmlRsp mutant
(white squares) and the adhC mutant (black circles).
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not play a role either directly or via regulatory effects in the
adherence of S. pneumoniae to human respiratory epithelial cells
in vitro or to the murine nasopharynx in vivo but that it is of
considerable importance during invasive disease.
DISCUSSION
Little is known about the role played by NO in the clearance of
pneumococcal infections and even less about the defense mech-
anisms that pneumococci use to protect against reactive nitro-
gen species. Our results show that defense against NO in pneu-
mococcus includes at least 2 proteins, AdhC and NmlRsp. Our
data usingwild-typeD39 cells and the adhCmutant clearly show
that AdhC catalyses the NADH-dependent reduction of GSNO.
We therefore propose that this system is one mechanism
whereby S. pneumoniae resists NO stress. Although this enzyme
is present in Salmonella Typhimurium, it does not appear to be
essential for its virulence in mice [4].
We initially considered the NmlR subfamily of MerR regula-
tors to be a single clade [16], but clearly there is considerable
diversitywithin this subfamily.NmlRsp is different fromall of the
other forms of NmlR that we have identified. The differences in
the number and position of cysteine residues inNmlR regulators
suggests that there may be differences in the way in which they
sense stress induced by NO or other oxidants.
In a number of bacteria, an adhC-like gene is associated with
an NmlR-like regulator [16], and this is the case for S. pneu-
moniae. However, there are some important differences between
the organization of the pneumococcal and gonococcal gene clus-
ters. First, the pneumococcal adhC and nmlR are cotranscribed,
whereas, in the gonococcus, the 2 genes are transcribed from
opposite DNA strands. It follows that the promoter regions dif-
fer and the gonococcal adhC-nmlR exhibits divergent overlap-
ping promoters with NmlR-binding sites, a genetic organization
that is typical of the majority of MerR-regulated systems. Sec-
ond, unlike inN. gonorrhoeae, there is no esterase-encoding gene
distal to adhC in S. pneumoniae [16]. Examination of the adhC-
nmlRsp gene clusters in other Streptococcus species have revealed
that they all have a similar genetic organization to that found in
S. pneumoniae. We were able to show that adhC is induced by
GSNO. This induction required NmlRsp, because adhC in the
nmlRspmutantwas no longer inducible. Furthermore, thenmlRsp
mutant showed a reduced level of adhCmRNA, suggesting that
nmlRsp acts as a transcription activator for adhC. Because the erm
cassette lacks a promoter or transcription terminator, such
insertion-replacement mutations are nonpolar, and all previous
insertion mutants of this type have never shown any polar ef-
fects. Thus, it seems unlikely that the reduction of adhC tran-
scription seen in this nmlRsp mutant is due to polarity.
During the normal course of S. pneumoniae infection, the or-
ganism translocates from the nasopharynx to the lungs and sub-
sequently to the blood to cause bacteremia. In the lungs, the
bacteria will encounter large numbers of resident macrophages
that are part of the innate immune system. Once the pneumo-
cocci are phagocytosed the internalized bacteria are subject to
killing by bactericidal agents, including NO. The pneumococcal
toxin pneumolysin is known to contribute significantly to lung
damage during pneumonia, and one mechanism involves the
triggering of NO production in macrophages [2]. This leads to
apoptosis of the macrophage but, in so doing, also places the
bacteria under considerable NO stress. The nmlRsp-adhC system
appears to be an important mechanism whereby the bacteria
could protect themselves from elevated NO levels. This does not
appear to be important during the nasophayngeal coloniza-
tion phase, and competitive-index data from the intranasal-
challenge experiments suggests at best a modest effect in the
lungs. Furthermore, mutation of adhC or nmlRsp does not affect
the growth rate of S. pneumonieae in vitro (S.P.K., S.L.S., and
A.G.M., unpublished data), and this indicates that neither gene
is required during growth in the absence of nitrosative stress.
However, once the bacteria cross into the blood, they encounter
not only pulmonary macrophages but also neutrophils, which
are also capable of killing via NO. Our data clearly show that, in
the blood, there is a significant decrease in the fitness of the
nmlRsp and adhCmutants compared with that of wild-type D39
S. pneumoniae,which correlated with in vitro AdhC activity and
resistance to GSNO challenge. The nmlRsp-adhC system is the
first NO resistance mechanism to be described for S. pneu-
moniae, and our data underscore the importance of this system
for countering innate host defences during invasive pneumococ-
cal disease.
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